Funded Tech Companies
FesariusTherapeutics
Looking for the VC firms that provided funding to FesariusTherapeutics? Johnson & Johnson Development Corporation and New York Ventures joined the equity holders in this innovative medical devices company.
Company Overview
Company Name
FesariusTherapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
619 W 54th St, The Hudson Research Building - 9th Floor
New York, NY 10019
USA
New York, NY 10019
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
FesariusTherapeutics - the cutting-edge biotech start-up on a mission to revolutionize the world of regenerative medicine. We are dedicated to developing innovative tissue-engineered products to transform reconstructive and aesthetic surgery. Founded in 2015, based upon technology spun-out from The Laboratory for Bioregenerative Medicine and Surgery at Weill Cornell Medicine, FesariusTherapeutics has developed DermiSphereTM, a revolutionary dermal regeneration template (DRT) for the management of wounds.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/10/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tom Roueche
Chief Scientific Officer
Yulia Sapir-Lekhovitser
Co-Founder
Brett Spector
Founder
Jason Spector
VP - Sales
Tim O'Brien
Company Investors
- Johnson & Johnson Development Corporation
- New York Ventures
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs